Generic Drugs: Osimertinib EGFR T790M

Osimertinib is a special kind of medicine that stops a mutation called T790M in the EGFR, which is often what happens in NSCLC patients who’ve already had EGFR-TKI treatment. You can get osimertinib in 40 mg or 80 mg tablets, but the usual amount is 80 mg taken every day, and it doesn’t matter if you have it with or without food.